CHI Memorial Hospital has added a urinary tract infection clinic to its host of services. The clinic provides comprehensive ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

UTIs occur more often in women because they have shorter urethras than men. UTI risk increases ... opportunistic infections. When indicated, antibiotics are the treatment of choice for symptomatic ...

Urinary tract infections (UTIs) are recognized as the second most common medical condition, following respiratory infections. Despite the availability of numerous efficacious antibiotics for the ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Several conditions can lead to urinary flow problems. In men, prostate changes often affect urination patterns, particularly ...

ensuring efficient and effective treatment. Most UTI infections involve the lower urinary tract and are caused by bacteria. Women are more likely than men to develop a UTI. Common UTI symptoms ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Pelvic floor dysfunction results in miscoordination between pelvic muscles, organs, and the brain. Find treatment for a tight ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...